相关实验视频
Updated: Jan 11, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.9K
在阿尔茨海默氏症的疾病中纳米级tau聚合物的形态和高酸化过渡
Adriana N Santiago-Ruiz1,2, Siewert Hugelier2, Gabriela L Correa3
1Biochemistry, Biophysics, and Chemical Biology Graduate Group, University of Pennsylvania, Philadelphia, USA.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 19, 2025
概括
在阿尔茨海默病 (AD) 中至关重要的纳米大小的聚合物显示出明显的酸化模式,区分健康和病态. 它们的尺寸和复杂性随着AD的进展而增加,提供新的诊断见解.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 陶聚合成神经纤维状 (NFTs) 是阿尔茨海默病 (AD) 病理学的核心.
- 新兴的研究确定了纳米大小的寡合体作为潜在的有毒实体.
- 了解纳米级的tau对于破译疾病机制至关重要.
研究的目的:
- 为了可视化和表征人类大脑组织中的纳米大小的聚物 (纳米聚物) 在不同的病症条件下.
- 调查纳米聚合物的高酸化特征和形态特征在AD,初级年龄相关陶病 (PART) 和对照中.
- 根据分子和结构性质来区分生理和病理的tau纳米聚合物.
主要方法:
- 使用超分辨率显微镜可视化死后人类大脑组织中的纳米聚合物.
- 免疫组织化学被用来检测tau上的特定过酸化部位,包括p-T231,p-T181和p-S202/T205.
- 对纳米聚合物进行了形态分析,以评估尺寸和复杂性.
主要成果:
- 在对照病例中发现了在p-T231和p-T181上过酸化的Tau纳米聚合物,这表明了生理作用.
- 具有p-S202/T205高酸化的纳米聚合物特别与AD和PART相关.
- 纳米聚合物在AD中增加了大小和复杂性,在高级AD中,与中级AD中的单个站点相比,高级AD显示了多个过酸化位.
结论:
- 纳米聚合物的明显的高酸化模式可以区分生理和病理状态.
- 纳米聚合物的形态变化与病的疾病进展相关.
- 这项研究为检测和分析纳米级聚物提供了一个框架,为了解病症开辟了新的途径.
更多相关视频
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
9.4K
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
19.3K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K